nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2025, 03, v.27 124-129
基于数据挖掘仝小林应用穿山龙治疗甲状腺疾病的药物配伍规律及安全性分析
基金项目(Foundation): 科技部国家重点研发计划“主动健康和老龄化科技应对专项”(2020YFC2002700); 中央高水平中医医院临床科研业务费资助项目(HLCMHPP2023084); 中国中医科学院科技创新工程中医药防治内分泌代谢病科技创新团队资助项目(CI2021B008); 中国中医科学院广安门医院临床医学研究中心建设专项培育项目(2022LYJSZX17)
邮箱(Email):
DOI: 10.13194/j.issn.1673-842X.2025.03.022
摘要:

目的 总结探析仝小林院士应用穿山龙治疗甲状腺疾病的药物配伍规律,为穿山龙治疗甲状腺疾病提供参考。方法 收集2015年1月—2023年1月在仝小林院士门诊就诊的患有甲状腺疾病且处方内含有穿山龙患者的病历,采用SPSS Statistics 26软件进行频数统计,SPSS Modeler 18.0软件进行关联规则分析和SPSS Statistics26软件的系统聚类方法进行聚类分析及对患者应用穿山龙治疗前后的肝功能进行统计分析,分析仝小林院士应用穿山龙治疗甲状腺疾病的药物配伍规律及安全性分析。结果 对仝小林院士使用穿山龙治疗甲状腺疾病常用的药物配伍经验进行分析总结,频数统计显示仝小林院士在治疗甲状腺疾病时用药以温、寒、平之性为主;药味以甘、苦、辛为主;用药归经以肝经为主,其次为脾、肺、肾、胃等,关联规则分析显示在治疗甲状腺疾病时最常用的靶方为穿山龙-三七-莪术-浙贝母;在不同原因所导致的甲状腺功能减退中用穿山龙-黄芪-当归-淫羊藿治疗气血亏虚、阳气不足之虚态,态靶同调;以穿山龙-夏枯草-牡蛎-五味子为治疗甲状腺结节之靶方,聚类分析得出仝小林院士常用来与穿山龙相配伍治疗甲状腺疾病的常用药物配伍。结论 穿山龙药性平和,靶向明确,仝小林院士在治疗甲状腺疾病时擅长运用“态靶辨治”的思想,通过不同配伍将穿山龙用于甲状腺疾病的治疗,且对于肝功能没有不良影响,对临床应用穿山龙治疗甲状腺疾病具有一定的指导意义。

Abstract:

Objective To summarize and analyze the drug compatibility rule of Professor TONG Xiaolin's application of Chuanshanlong(Dioscoreae Nipponicae Rhizoma) in the treatment of thyroid diseases,and to provide reference for Chuanshanlong(Dioscoreae Nipponicae Rhizoma) in the treatment of thyroid diseases. Methods From January 2015 to January 2023,medical records of patients with thyroid disease and prescription containing Chuanshanlong(Dioscoreae Nipponicae Rhizoma) in Professor TONG Xiaolin's outpatient department were collected. SPSS Statistics 26 software was used for frequency statistics.SPSS Modeler 18.0 software was used for association rule analysis and SPSS Statistics 26 software was used for systematic clustering analysis and statistical analysis of patients' liver function before and after Chuanshanlong(Dioscoreae Nipponicae Rhizoma) treatment,as well the drug compatibility rule and security of Academician TONG Xiaolin's application of Chuanshanlong(Dioscoreae Nipponicae Rhizoma) in the treatment of thyroid diseases was analyzed. Results Professor TONG Xiaolin's experience of using Chuanshanlong(Dioscoreae Nipponicae Rhizoma) in the treatment of thyroid diseases was analyzed and summarized. The frequency statistics showed that Professor TONG Xiaolin used warm,cold and calm drugs in the treatment of thyroid diseases. The taste of medicine is mainly sweet,bitter and xin. Liver channel was the main channel,followed by spleen,lung,kidney,stomach,etc. Association rule analysis showed that the most commonly used targets in the treatment of thyroid diseases were Chuanshanlong(Dioscoreae Nipponicae Rhizoma)-Sanqi(Notoginseng Radix Et Rhizoma)-Ezhu(Curcumae Rhizoma)-Zhebeimu(Fritillariae Thunbergii Bulbus) in hypothyroidism caused by different reasons,Chuanshanlong(Dioscoreae Nipponicae Rhizoma)-Huangqi(Astragali Radix)-Danggui(Angelicae Sinensis Radix)-Yinyanghuo(Epimedii Wushanensis Folium) was used to treat the deficiency of Qi and blood,and the deficiency of Yang-Qi. Taking Chuanshanlong(Dioscoreae Nipponicae Rhizoma)-Xiakucao(Prunellae Spica)-Muli(Ostreae Concha)-Wuweizi(Schisandrae Chinensis Fructus) as the target for treating thyroid nodules,cluster analysis showed that Academician TONG Xiaolin was commonly used to match Chuanshanlong(Dioscoreae Nipponicae Rhizoma) with common drugs for treating thyroid diseases. Conclusion The drug of Chuanshanlong(Dioscoreae Nipponicae Rhizoma)is peaceful and the target is clear. Professor TONG Xiaolin is good at using the idea of “differentiation of state and target treatment” in the treatment of thyroid diseases. Through different compatibility,Chuanshanlong(Dioscoreae Nipponicae Rhizoma) is used in the treatment of thyroid diseases,and there is no adverse effect on liver function,which has certain guiding significance for the clinical application of Chuanshanlong(Dioscoreae Nipponicae Rhizoma) in thetreatment of thyroid diseases.

参考文献

[1]初阳,冷锦红.穿山龙与古籍中萆薢的应用对比研究[J].山东中医杂志,2020,39(5):513-516.

[2]耿雯雯,张湘苑,乔丽萍,等.重构本草——穿山龙[J].吉林中医药,2023,43(4):468-470.

[3]田卫卫,魏燕.仝小林教授运用穿山龙经验[J].吉林中医药,2020,40(5):589-592.

[4]国家药典委员会.中华人民共和国药典(一部)[S].北京:中国医药科技出版社,2020.

[5]国家中医药管理局《中华本草》编委会.中华本草(9)[M].上海:上海科学技术出版社,1999.

[6]高学敏,钟赣生.临床中药学[M].石家庄:河北科学技术出版社,2005.

[7]刘萍,王平,刘松林,等.基于药对探讨中药复方配伍规律的思考[J].中华中医药学刊,2010,28(9):1833-1835.

[8]仝小林.维新医集[M].上海:上海科学技术出版社,2020.

[9]谢瑞芳,林评兰,王瑛,等.不同配伍比例当归补血汤化学成分及促血管新生作用比较[J].中国中医药信息杂志,2016,23(6):83-87.

[10]郭静,莫友胜,王奇,等.当归补血汤对内皮祖细胞氧化应激损伤的保护作用[J].中国实验方剂学杂志,2020,26(20):39-45.

[11]王贞贞,赵泉霖,姬翔,等.芪归药对防治糖尿病心肌病的研究进展[J].中国中医急症,2020,29(9):1674-1676,1685.

[12]宋跃朋.当归四逆汤合补阳还五汤加减治疗糖尿病下肢血管病变的临床疗效[J].临床合理用药杂志,2018,11(30):110-111.

[13]黄丽萍,陈耀辉,吴素芬,等.当归补血汤含药血清对血虚小鼠骨髓造血功能的影响[J].中药药理与临床,2014,30(2):18-20.

[14]王翰飞,潘孜文,朱向东,等.仝小林从异病同治辨治“女性三联征”的思路和经验探讨[J].辽宁中医杂志,2020,47(3):63-66.

[15]张莉莉,韦宇,方心怡,等.夏枯草、黄药子、五味子治疗甲状腺功能亢进症经验——仝小林三味小方撷萃[J].吉林中医药,2020,40(5):568-570.

[16]何春玲.茵兰益肝颗粒治疗急性药物性肝损伤69例[J].中国药业,2014,23(24):110-111.

基本信息:

DOI:10.13194/j.issn.1673-842X.2025.03.022

中图分类号:R259

引用信息:

[1]李梦甜,耿雯雯,乔丽萍,等.基于数据挖掘仝小林应用穿山龙治疗甲状腺疾病的药物配伍规律及安全性分析[J].辽宁中医药大学学报,2025,27(03):124-129.DOI:10.13194/j.issn.1673-842X.2025.03.022.

基金信息:

科技部国家重点研发计划“主动健康和老龄化科技应对专项”(2020YFC2002700); 中央高水平中医医院临床科研业务费资助项目(HLCMHPP2023084); 中国中医科学院科技创新工程中医药防治内分泌代谢病科技创新团队资助项目(CI2021B008); 中国中医科学院广安门医院临床医学研究中心建设专项培育项目(2022LYJSZX17)

投稿时间:

2024-05-06

投稿日期(年):

2024

终审时间:

2024-10-14

终审日期(年):

2024

审稿周期(年):

1

发布时间:

2024-10-17

出版时间:

2024-10-17

网络发布时间:

2024-10-17

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文